The NF-?B Pharmacopeia: Novel Strategies to Subdue an Intractable Target (2022)
Attributed to:
Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/biomedicines10092233
PubMed Identifier: 36140335
Publication URI: http://europepmc.org/abstract/MED/36140335
Type: Journal Article/Review
Parent Publication: Biomedicines
Issue: 9
ISSN: 2227-9059